Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32688534 | 0.85 | ALDH1A1 (0.50) | EPHX2ALDH1A1SIRT5USP2ALOX15 | |
| SCHEMBL32688856 | 0.79 | ALDH1A1 (0.42) | EPHX2DGKAALDH1A1 | |
| SCHEMBL32688661 | 0.79 | CYP19A1 (0.44) | EPHX2DGKAALDH1A1HTR2CNAAA | |
| SCHEMBL32689133 | 0.79 | MEN1 (0.43) | EPHX2ALDH1A1SIRT5NPSR1TDP1 | |
| SCHEMBL32688760 | 0.76 | SIRT5 (0.52) | EPHX2ALDH1A1SIRT5TDP1 | |
| SCHEMBL32688733 | 0.76 | ALDH1A1 (0.44) | EPHX2ALDH1A1SIRT5TDP1 | |
| SCHEMBL25633481 | 0.75 | EPHX2 (0.45) | EPHX2DGKAALDH1A1HTR2CNAAA | |
| SCHEMBL29550087 | 0.75 | DGKA (0.41) | EPHX2DGKAALDH1A1HTR2CNAAA | |
| SCHEMBL32688972 | 0.75 | NPC1 (0.40) | EPHX2ALDH1A1NPSR1 | |
| SCHEMBL28820927 | 0.75 | DGKA (0.50) | EPHX2DGKAALDH1A1HTR2CNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | EPHX2 154/4885DGKA 3805/4885ALDH1A1 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.